The face of the patent is not the ‘‘Whole Story’’: determining effective life of a pharmaceutical patent in the United States
-
Drug Patents: A New Hedge Fund Target – Courtesy ( Seeking Alpha.com)
Pharma Live, , Intellectual Property Rights, 0
Summary Hedge funds managers are attacking what they see as “weak patents” held by pharmaceutical companies while they are...
-
Stempeutics Gets Stem Cell Patent In China (Chinese Application Number: CN201080053627) For Its Novel Stem Cell Drug ‘Stempeucel’ – Courtesy(Biospace)
Pharma Live, , Intellectual Property Rights, 0
Stempeutics Research, a group company of Manipal Education and Medical Group and a Joint Venture with Cipla Group, announced...
-
Suven Life’s NCEs for neurodegenerative diseases receive European & Hong Kong patents – Courtesy(Pharmabiz.com)
Pharma Live, , Intellectual Property Rights, 0
Suven Life Sciences Ltd (Suven), a Hyderabad-based biopharmaceutical company focussed on discovering, developing and commercialising novel pharmaceutical products, has...
-
Here’s a lucrative idea: Turn a drug into an orphan med, reap 6 months extra exclusivity – Courtesy (Fierce Pharma)
Pharma Live, , Intellectual Property Rights, 0
Would-be makers of rare disease meds, rejoice: A 6-month exclusivity extension, proposed last year in Congress, has returned. The 21st...
-
Court Cites Objects Of Invention In Claim Construction – Courtesy (Pharma Patents)
Pharma Live, , Intellectual Property Rights, 0
POSTED BY COURTENAY C. BRINCKERHOFF ON 24 FEBRUARY 2015POSTED IN CLAIM CONSTRUCTION;FEDERAL CIRCUIT DECISIONSPacing Technologies, LLC v. Garmin International, Inc. is one of...
-
Louisiana Challenge’s AstraZeneca on Antitrust Claims for Asserting Invalid Drug Patents – Courtesy(PATENTLYO)
Pharma Live, , Intellectual Property Rights, 0
In March 2015, the state of Louisiana filed suit against AstraZeneca alleging antitrust violations based upon the company’s actions of...
-
Orphan drug market to reach $176bn by 2020 – Courtesy ( PMLiVe)
Pharma Live, , Intellectual Property Rights, 0
pharmacistThe global orphan drug market is expected to account for 19% of all branded prescription drug sales by 2020,...
-
Patents Against People: How Drug Companies Price Patients out of Survival – Courtesy (Dissent)
Pharma Live, , Intellectual Property Rights, 0
As our television screens toggle between pundits squabbling over Obamacare’s insurance rules and ads for erectile dysfunction remedies, another...
![](https://interactivepharm.com/wp-content/uploads/2022/08/Show-your.jpg)